Large Difference in Survival Seen for Preemies Born at 25 Versus 22 Weeks
FRIDAY, Sept. 27, 2024 -- For infants born prematurely, survival increases considerably for those born at 25 versus 22 gestational weeks, according to a study published online Sept. 26 in Pediatrics.
Erika M. Edwards, Ph.D., M.P.H., from Vermont Oxford Network in Burlington, and colleagues examined survival to hospital discharge for infants born at 22 to 25 weeks of gestation at a hospital with a level 3 or 4 neonatal intensive care unit from 2020 to 2022.
The analyses included 22,953 infants at 636 U.S. hospitals. The researchers observed an increase in postnatal life support from 68.0 to 99.8 percent at 22 and 25 weeks, respectively. From 2020 to 2022, there was an increase seen in the proportion of infants born at 22 weeks receiving postnatal life support, from 61.6 to 73.7 percent. Survival for all infants varied from 24.9 to 82.0 percent at 22 and 25 weeks, respectively. Among infants receiving postnatal life support, survival varied from 35.4 to 82.0 percent at 22 and 25 weeks, respectively, while the corresponding survival without severe complications varied from 6.3 to 43.2 percent. The median length of stay varied from 160 to 110 days at 22 and 25 weeks, respectively. Among survivors, the rates of technology dependence at discharge home were higher for infants born at 22 weeks than those born at later gestational ages.
"These contemporary data should help providers and families who are making decisions about the management of infants born at 22 to 25 weeks' gestation," the authors write.
Vermont Oxford Network has received funding from Vitara Biomedical.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.